recent reports of serious concern regarding the safe clinical use of phenylbutazone and its hydroxylated metabolite ( oxyphenbutazone ) as antiinflammatory agents have prompted the further investigation of ring-opened ( malonamide ) derivatives as potentially preferable therapeutic derivatives .
C0031463
phenylbutazone
C0030078
oxyphenbutazone